Search Login Register
Hypothyroidism
Summary
8111
relevant articles (220 outcomes,
634 trials/studies)
found for this Disease
Description:
A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA.
Also Known As:
Hypothyroidisms
Key Drugs and Agents for Hypothyroidism
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Thyroxine (Levothyroxine)
:
55 outcomes 141 studies in 1559 results
:
FDA 14
Generic
-
Hormones
:
26 outcomes 78 studies in 1045 results
: IBA
-
Iodine
:
15 outcomes 36 studies in 565 results
: IBA
-
Thyrotropin (Thyroid-Stimulating Hormone)
:
14 outcomes 38 studies in 774 results
:
FDA 1
-
Thyroid Hormones
:
9 outcomes 24 studies in 303 results
: IBA
-
Propylthiouracil
:
8 outcomes 18 studies in 265 results
:
FDA 15
-
Antibodies
:
7 outcomes 25 studies in 417 results
: IBA
-
Amiodarone (Amiodarona)
:
5 outcomes 5 studies in 193 results
:
FDA 4
Generic
-
Cholesterol
:
4 outcomes 16 studies in 178 results
: IBA
-
Triiodothyronine (Liothyronine)
:
4 outcomes 14 studies in 308 results
:
FDA 1
Show All >>
Diseases Related to Hypothyroidism
-
Hyperthyroidism
-
Graves Disease (Basedow Disease)
-
Thyroid Neoplasms (Thyroid Cancer)
-
Goiter
-
Thyroid Diseases (Thyroid Disease)
Show All >>
Key Therapies for Hypothyroidism
Efficacy Chart >>
-
Aftercare (After-Treatment)
:
8 outcomes 9 studies in 162 results
-
Thyroidectomy
:
7 outcomes 22 studies in 277 results
-
Hormone Replacement Therapy (Therapy, Hormone Replacement)
:
5 outcomes 13 studies in 92 results
-
Drug Therapy (Chemotherapy)
:
2 outcomes 4 studies in 62 results
-
Hypophysectomy
:
2 outcomes 1 study in 20 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2009 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.